曼诺基化STING激动剂药物对象用于树突细胞介导癌症免疫治疗

Dinh Chuong Nguyen1, Kefan Song2, Simbarashe Jokonya2

  • 1Molecular Engineering & Sciences Institute, University of Washington, Seattle, Washington 98195, United States.

ACS central science
|April 1, 2024
PubMed
概括

一种新型的聚合原药,polySTING,有效地将STING激动剂传递给抗原呈现细胞,增强抗瘤免疫力并减少癌症免疫疗法的毒性.